New hope for tough-to-treat breast cancer: experimental drug combo enters human trials
Disease control
Ongoing
This early-stage trial is testing a new drug called ARV-471, both alone and combined with an existing cancer drug (palbociclib), for people with advanced breast cancer that has stopped responding to hormone therapy and chemotherapy. The study aims to find safe doses and see if th…
Phase: PHASE1, PHASE2 • Sponsor: Arvinas Estrogen Receptor, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC